Companies / Pulse Biosciences, Inc.

Pulse Biosciences, Inc.

Nasdaq: PLSECIK 1625101HAYWARD, CA

Financials · FY2025

Revenue$350.0K
Net income$-72.78M
Total debt
Cash$101.62M
Diluted EPS
Shares outstanding71.3M

Ownership

71.3M shares outstanding · as of Jul 31, 2026
67.7%Insiders
Ownership
Insiders67.68%48,269,731
Institutions10.22%7,287,809
Public float22.10%15,765,067

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 5

View all →
Insider% of sharesShares
Robert W. DugganDirector · 10% owner
67.60%48,211,433
Danahy Kevin PatrickChief Commercial Officer
0.06%43,298
Laviolette Paul aCEOChief Executive Officer · Director
0.02%15,000
Sainz MariaFormerDirector
Uecker DarrinChief Technology Officer · Director

Institutional holders 89

View all →

Activity

Jun 30, 2026View all →
InsidersInstitutions
Who's accumulating and trimming this stock (13F).
DateActorActionSecurityValueShares ΔPosition afterImpact
Q1 2026
as of
Portolan Capital Management, LLC
13F manager
AddCommon Stock$7.34M+340K
+86.37%
733,372
1.03% of shares
medium
Q1 2026
as of
Balyasny Asset Management L.P.
13F manager
NewCommon Stock$5.72M+265K
265,164
0.37% of shares
medium
Q2 2026
as of
BlackRock, Inc.
13F manager
AddCommon Stock$3.04M+110K
+8.08%
1,466,702
2.06% of shares
low
Q2 2026
as of
State Street Corporation
13F manager
AddCommon Stock$2.29M+83K
+18.47%
529,624
0.74% of shares
low
Q1 2026
as of
Millennium Management LLC
13F manager
NewCommon Stock$1.21M+56K
55,817
0.08% of shares
low
Q1 2026
as of
Formula Growth Ltd
13F manager
NewCommon Stock$647.7K+30K
30,000
0.04% of shares
low
Q1 2026
as of
Geode Capital Management, LLC
13F manager
AddCommon Stock$590.2K+27K
+5.88%
491,946
0.69% of shares
low
Q3 2024
as of
Barclays PLC
13F manager
AddCommon Stock$416.4K+24K
+361.42%
30,306
0.04% of shares
low

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
PLSECommon StockEquity74587B101BBG00BRBHVD0